AltStreet
EDGAR Verified
Primary Source · SEC.gov

Ishara Biotech Fund LP

CIK 0002052609Fund Vehicle2026 vintage506(b), 3(c)(1)

Raised

$8M

Investors

11

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Ishara Biotech Fund LP is a Delaware limited partnership that has raised $8.5M from 11 investors under Rule 506(b) and Section 3(c)(1). This amended filing reports activity for a pooled investment fund focused on longevity biotechnology, managed by Ishara Partners GP, LLC and affiliated entities including executive officer Shaun Mehra. Minimum investment amount was not disclosed on the filing.

This longevity biotech fund follows the typical 506(b) / 3(c)(1) exemption pattern common to private life sciences funds targeting accredited investors. With $8.5M raised from 11 investors, the average commitment of approximately $773K suggests an institutional or high-net-worth investor base, consistent with early-stage biotech venture funds in this category.

Data Flags

related personsTwo executive officer entities listed (Ishara Partners GP, LLC and Ishara Investments LP) in addition to individual Shaun Mehra, suggesting a multi-layered GP structure
generalPlatform description indicates 0 related EDGAR entities despite presence of multiple affiliated entities (GP, Ishara Investments LP) listed in the filing

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002052609
Entity NameIshara Biotech Fund LP
Exemption506(b), 3(c)(1)
First Sale Date—
Filing DateJanuary 20, 2026
Accession Number0001104659-26-005001
Total Amount Sold$8M
Total Investors11
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

N/A Ishara Partners GP, LLC

Executive Officer · Los Angeles, CA

N/A Ishara Investments LP

Executive Officer · Los Angeles, CA

Shaun Mehra

Executive Officer · Los Angeles, CA

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.